‘డయాబెటిస్ రోగులకు గుడ్న్యూస్: వారానికి ఒక్క షాట్తో చికిత్స’
Novo Nordisk launches once-weekly insulin Awiqli in India, offering convenience for type 2 diabetes patients, reducing injections from 365 to 52 yearly. Experts highlight improved compliance, but stress it’s not universal; daily insulin may suit those needing flexible dosing. Consult a doctor before switching.